Purdue’s Chao Center regains drug, slashes $360-per-pill price
An Indiana not-for-profit has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90 percent after re-acquiring rights to the medicine from Rodelis Therapeutics.
Health Care & Life Sciences
Articles
Anthem, Aetna defend acquisitions called harmful by hospitals
Anthem Inc. CEO Joseph Swedish and Aetna Inc. CEO Mark Bertolini will tell federal lawmakers Tuesday that the deals are necessary to succeed in a changing health-care landscape.
Analyst: Lilly’s Jardiance diabetes pill could be a $6 billion-a-year blockbuster
It looks like Eli Lilly and Co. finally has a drug that can replace its former stars Zyprexa and Cymbalta. The most bullish analysts think Jardiance can surpass those $5 billion-a-year blockbusters.
Lilly stock performs big despite analyst projections
Analysts have consistently given the Indianapolis-based company some of the lowest ratings among a group of 16 large drugmakers, but Lilly shares have been on a five-year rally.
American Senior Communities fires chief executive
The dismissal of James Burkhart as head of the Indianapolis-based nursing home company comes three days after FBI agents raided his Carmel home.
Lilly’s heart study sets up showdown with Novo’s Victoza
Unprecedented results from a cardiovascular study on a diabetes medicine sold by Eli Lilly and Co. turns up the pressure on rival Novo Nordisk, which will release data from a similar study on its competing drug next year.
Group urges Dems to tackle pharmaceutical prices
Pharmaceutical industry members are likely to dislike the proposal, which would require them disclose how much they spend on research and development, production, and sales and marketing.
Hospital-owned docs send more patients to lower-quality, higher-cost hospitals
When hospitals employ doctors—which is now the norm in central Indiana—more of those doctors’ patients end up going to hospitals with higher costs and poorer quality, according to a new study.
Jardiance study lifts Lilly shares to 15-year high
Eli Lilly shares soared Thursday after study results showed Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications. The study prompted at least one analyst to predict the drug could bring in billions of dollars by the end of the decade.
Lilly shares jump on latest data from diabetes drug
A diabetes pill called Jardiance sold by Eli Lilly and Co. cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world’s most rampant health epidemics.
Senior health care firm operator Trilogy sold in $1.2B deal
Trilogy Health Services LLC, which operates more than 70 senior-living facilities in Indiana, is being acquired. The company has at least 14 properties in central Indiana, including two in Indianapolis.
Obamacare pumping more than $2B into Hoosier health insurers
A flood of money from Obamacare—for the expanded Healthy Indiana Plan and for private health insurance purchased on the federal exchange—is boosting revenue and profit among Indiana health insurers.
Drug-price increases slow as benefits managers get tough
A new analysis shows attempts by drugmakers to raise prices are being wiped out in negotiations with managers of drug insurance benefits like Express Scripts Holding Co. and CVS Health Corp.
Retail clinics, apps change doctor-patient relationship
A shortage of primary care physicians and emerging alternatives such as retail clinics and smartphone apps are changing the way patients access the U.S. health care system.
AMA: Anthem, Aetna deals threaten competition across nation
The market for health-insurance in the U.S. is already so highly concentrated that pending tie-ups among four of the country’s largest insurers risk hurting both consumers and doctors, the American Medical Association said.
More precise medical codes aim to track quality of care
On Oct. 1, the nation’s physicians and hospitals must start using a massive new coding system to describe your visit on insurance claims so they get paid.
IUPUI receives $1.9M grant for health workforce diversity
The grant will enable researchers at IU's Indianapolis medical campus to develop and implement the IU Health Careers Opportunity Program.
Community set to go whole hog on new value-based payments
CEO Bryan Mills has set a goal to make 75 percent of revenue—or $1.5 billion a year—be covered by value-based contracts—which means Community would be rewarded for keeping patients out of the hospital. A new venture is Mills’ strategy to get there.
Senior housing planned on key 86th and Meridian corner
A Missouri-based development team wants to build a $10 million senior living center on the last available parcel at one of the north side’s most visible intersections.
Marian starts search for new med school dean
Marian University expects the deans of both its medical and nursing schools to retire in the next two years. So, the small Catholic school is launching a search for replacements.